Biotechnology Human Microbiome Sequencing Technol...

Human Microbiome Sequencing Technology Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Traditional Sequencing Technologies, Next-Generation Sequencing, Third Generation Sequencing); End User (Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, Others) and Geography

Report Code: TIPRE00012479 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Path to genome sequencing has changed human microbiome research from focusing on identity characterizations to metagenomics strategies that reveal not only microbial species but also how microbial metabolic activities correlate with human health and disease. The interaction between the human microbiome and the immune system has an effect on several human metabolic activity. Research studies are going on to identify the relation between composition between the microbiome and infectious disease.

MARKET DYNAMICS

The human microbiome sequencing technology market is driving due to the rise in research and development activity in the field of human genome sequencing, advancement in next-generation sequencing (NGS) and other technologies . However, the lack of skilled professional in human microbiome sequencing are expected to hamper the growth of the global human microbiome sequencing technology market.

MARKET SCOPE

The "Human Microbiome Sequencing Technology Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Human Microbiome Sequencing Technology market with detailed market segmentation by type and end user. The Human Microbiome Sequencing Technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Human Microbiome Sequencing Technology market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Human Microbiome Sequencing Technology market is segmented on the basis of type and application. Based on type, the market is segmented as Traditional Sequencing Technologies,Next-Generation Sequencing,Third Generation Sequencing. On the basis of end user, the market is categorized as Research and Academic Institutions, Pharmaceutical and Biotechnology Companies and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Microbiome Sequencing Technology market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Microbiome Sequencing Technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Human Microbiome Sequencing Technology market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Microbiome Sequencing Technology market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the Human Microbiome Sequencing Technology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Microbiome Sequencing Technology market are anticipated to have lucrative growth opportunities in the future with the rising demand for Human Microbiome Sequencing Technology in the global market. Below mentioned is the list of few companies engaged in the Human Microbiome Sequencing Technology market.

The report also includes the profiles of key players in Human Microbiome Sequencing Technology market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pacific Biosciences of California, Inc.
  •  Thermo Fisher Scientific Inc.
  •  QIAGEN N.V.
  •  Microbiome Insights Inc.
  •  Leucine Rich Bio Pvt. Ltd.
  •  Second Genome, Inc.
  •  Illumina, Inc
  •  Charles River Laboratories International Inc.
  •  Oxford Nanopore Technologies, Inc.
  •  GENEWIZ, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS


1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Human Microbiome Sequencing Technology Market - By Type
1.3.2Human Microbiome Sequencing Technology Market - By End User
1.3.3Human Microbiome Sequencing Technology Market - By Region
1.3.3.1By Country

2.KEY TAKEAWAYS

3.RESEARCH METHODOLOGY

4.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS

5.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1.HUMAN MICROBIOME SEQUENCING TECHNOLOGY - GLOBAL MARKET OVERVIEW
6.2.HUMAN MICROBIOME SEQUENCING TECHNOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING/MARKET SHARE

7.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1.OVERVIEW
7.2.TYPE MARKET FORECASTS AND ANALYSIS
7.3.TRADITIONAL SEQUENCING TECHNOLOGIES
7.3.1.Overview
7.3.2.Traditional Sequencing Technologies Market Forecast and Analysis
7.4.NEXT-GENERATION SEQUENCING
7.4.1.Overview
7.4.2.Next-Generation Sequencing Market Forecast and Analysis
7.5.THIRD GENERATION SEQUENCING
7.5.1.Overview
7.5.2.Third Generation Sequencing Market Forecast and Analysis
8.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1.OVERVIEW
8.2.END USER MARKET FORECASTS AND ANALYSIS
8.3.RESEARCH AND ACADEMIC INSTITUTIONS
8.3.1.Overview
8.3.2.Research and Academic Institutions Market Forecast and Analysis
8.4.PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.4.1.Overview
8.4.2.Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
8.5.OTHERS
8.5.1.Overview
8.5.2.Others Market Forecast and Analysis

9.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1.NORTH AMERICA
9.1.1North America Human Microbiome Sequencing Technology Market Overview
9.1.2North America Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.1.3North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.1.4North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.1.5North America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.1.5.1United States Human Microbiome Sequencing Technology Market
9.1.5.1.1United States Human Microbiome Sequencing Technology Market by Type
9.1.5.1.2United States Human Microbiome Sequencing Technology Market by End User
9.1.5.2Canada Human Microbiome Sequencing Technology Market
9.1.5.2.1Canada Human Microbiome Sequencing Technology Market by Type
9.1.5.2.2Canada Human Microbiome Sequencing Technology Market by End User
9.1.5.3Mexico Human Microbiome Sequencing Technology Market
9.1.5.3.1Mexico Human Microbiome Sequencing Technology Market by Type
9.1.5.3.2Mexico Human Microbiome Sequencing Technology Market by End User
9.2.EUROPE
9.2.1Europe Human Microbiome Sequencing Technology Market Overview
9.2.2Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.2.3Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.2.4Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.2.5Europe Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.2.5.1Germany Human Microbiome Sequencing Technology Market
9.2.5.1.1Germany Human Microbiome Sequencing Technology Market by Type
9.2.5.1.2Germany Human Microbiome Sequencing Technology Market by End User
9.2.5.2France Human Microbiome Sequencing Technology Market
9.2.5.2.1France Human Microbiome Sequencing Technology Market by Type
9.2.5.2.2France Human Microbiome Sequencing Technology Market by End User
9.2.5.3Italy Human Microbiome Sequencing Technology Market
9.2.5.3.1Italy Human Microbiome Sequencing Technology Market by Type
9.2.5.3.2Italy Human Microbiome Sequencing Technology Market by End User
9.2.5.4Spain Human Microbiome Sequencing Technology Market
9.2.5.4.1Spain Human Microbiome Sequencing Technology Market by Type
9.2.5.4.2Spain Human Microbiome Sequencing Technology Market by End User
9.2.5.5United Kingdom Human Microbiome Sequencing Technology Market
9.2.5.5.1United Kingdom Human Microbiome Sequencing Technology Market by Type
9.2.5.5.2United Kingdom Human Microbiome Sequencing Technology Market by End User
9.3.ASIA-PACIFIC
9.3.1Asia-Pacific Human Microbiome Sequencing Technology Market Overview
9.3.2Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.3.3Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.3.4Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.3.5Asia-Pacific Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.3.5.1Australia Human Microbiome Sequencing Technology Market
9.3.5.1.1Australia Human Microbiome Sequencing Technology Market by Type
9.3.5.1.2Australia Human Microbiome Sequencing Technology Market by End User
9.3.5.2China Human Microbiome Sequencing Technology Market
9.3.5.2.1China Human Microbiome Sequencing Technology Market by Type
9.3.5.2.2China Human Microbiome Sequencing Technology Market by End User
9.3.5.3India Human Microbiome Sequencing Technology Market
9.3.5.3.1India Human Microbiome Sequencing Technology Market by Type
9.3.5.3.2India Human Microbiome Sequencing Technology Market by End User
9.3.5.4Japan Human Microbiome Sequencing Technology Market
9.3.5.4.1Japan Human Microbiome Sequencing Technology Market by Type
9.3.5.4.2Japan Human Microbiome Sequencing Technology Market by End User
9.3.5.5South Korea Human Microbiome Sequencing Technology Market
9.3.5.5.1South Korea Human Microbiome Sequencing Technology Market by Type
9.3.5.5.2South Korea Human Microbiome Sequencing Technology Market by End User
9.4.MIDDLE EAST AND AFRICA
9.4.1Middle East and Africa Human Microbiome Sequencing Technology Market Overview
9.4.2Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.4.3Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.4.4Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.4.5Middle East and Africa Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.4.5.1South Africa Human Microbiome Sequencing Technology Market
9.4.5.1.1South Africa Human Microbiome Sequencing Technology Market by Type
9.4.5.1.2South Africa Human Microbiome Sequencing Technology Market by End User
9.4.5.2Saudi Arabia Human Microbiome Sequencing Technology Market
9.4.5.2.1Saudi Arabia Human Microbiome Sequencing Technology Market by Type
9.4.5.2.2Saudi Arabia Human Microbiome Sequencing Technology Market by End User
9.4.5.3U.A.E Human Microbiome Sequencing Technology Market
9.4.5.3.1U.A.E Human Microbiome Sequencing Technology Market by Type
9.4.5.3.2U.A.E Human Microbiome Sequencing Technology Market by End User
9.5.SOUTH AND CENTRAL AMERICA
9.5.1South and Central America Human Microbiome Sequencing Technology Market Overview
9.5.2South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis
9.5.3South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Type
9.5.4South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By End User
9.5.5South and Central America Human Microbiome Sequencing Technology Market Forecasts and Analysis - By Countries
9.5.5.1Brazil Human Microbiome Sequencing Technology Market
9.5.5.1.1Brazil Human Microbiome Sequencing Technology Market by Type
9.5.5.1.2Brazil Human Microbiome Sequencing Technology Market by End User
9.5.5.2Argentina Human Microbiome Sequencing Technology Market
9.5.5.2.1Argentina Human Microbiome Sequencing Technology Market by Type
9.5.5.2.2Argentina Human Microbiome Sequencing Technology Market by End User

10.INDUSTRY LANDSCAPE
10.1.MERGERS AND ACQUISITIONS
10.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3.NEW PRODUCT LAUNCHES
10.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11.HUMAN MICROBIOME SEQUENCING TECHNOLOGY MARKET, KEY COMPANY PROFILES
11.1.PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
11.1.1.Key Facts
11.1.2.Business Description
11.1.3.Products and Services
11.1.4.Financial Overview
11.1.5.SWOT Analysis
11.1.6.Key Developments
11.2.THERMO FISHER SCIENTIFIC INC.
11.2.1.Key Facts
11.2.2.Business Description
11.2.3.Products and Services
11.2.4.Financial Overview
11.2.5.SWOT Analysis
11.2.6.Key Developments
11.3.QIAGEN N.V.
11.3.1.Key Facts
11.3.2.Business Description
11.3.3.Products and Services
11.3.4.Financial Overview
11.3.5.SWOT Analysis
11.3.6.Key Developments
11.4.MICROBIOME INSIGHTS INC.
11.4.1.Key Facts
11.4.2.Business Description
11.4.3.Products and Services
11.4.4.Financial Overview
11.4.5.SWOT Analysis
11.4.6.Key Developments
11.5.LEUCINE RICH BIO PVT. LTD.
11.5.1.Key Facts
11.5.2.Business Description
11.5.3.Products and Services
11.5.4.Financial Overview
11.5.5.SWOT Analysis
11.5.6.Key Developments
11.6.SECOND GENOME, INC.
11.6.1.Key Facts
11.6.2.Business Description
11.6.3.Products and Services
11.6.4.Financial Overview
11.6.5.SWOT Analysis
11.6.6.Key Developments
11.7.ILLUMINA, INC
11.7.1.Key Facts
11.7.2.Business Description
11.7.3.Products and Services
11.7.4.Financial Overview
11.7.5.SWOT Analysis
11.7.6.Key Developments
11.8.CHARLES RIVER LABORATORIES INTERNATIONAL INC.
11.8.1.Key Facts
11.8.2.Business Description
11.8.3.Products and Services
11.8.4.Financial Overview
11.8.5.SWOT Analysis
11.8.6.Key Developments
11.9.OXFORD NANOPORE TECHNOLOGIES, INC.
11.9.1.Key Facts
11.9.2.Business Description
11.9.3.Products and Services
11.9.4.Financial Overview
11.9.5.SWOT Analysis
11.9.6.Key Developments
11.10.GENEWIZ, INC.
11.10.1.Key Facts
11.10.2.Business Description
11.10.3.Products and Services
11.10.4.Financial Overview
11.10.5.SWOT Analysis
11.10.6.Key Developments

12.APPENDIX
12.1.ABOUT THE INSIGHT PARTNERS
12.2.GLOSSARY OF TERMS
The List of Companies

1. Pacific Biosciences of California, Inc.
2. Thermo Fisher Scientific Inc.
3. QIAGEN N.V.
4. Microbiome Insights Inc.
5. Leucine Rich Bio Pvt. Ltd.
6. Second Genome, Inc.
7. Illumina, Inc
8. Charles River Laboratories International Inc.
9. Oxford Nanopore Technologies, Inc.
10. GENEWIZ, Inc.
TIPRE00012479
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved